Gibson, Dunn & Crutcher LLP advised Royalty Pharma in connection with its development funding. Royalty Pharma plc (Nasdaq: RPRX) and Teva Pharmaceuticals International GmbH, a subsidiary...
Royalty Pharma’s Partnership with Teva Pharmaceuticals International GmbH
Veritas Capital’s $3.1 Billion Acquisition of Wood Mackenzie
Gibson, Dunn & Crutcher advised Veritas, while Davis Polk advised Verisk on the deal. Verisk announced the sale of its energy business, Wood Mackenzie, to an...